⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Gut–Liver–Heart Bile Acid Axis in Aging CAD
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-21 — β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.: 2026 NMN AFB1-liver-injury mouse study provides causal evidence (antibiotic depletion, FMT, intestine-specific FXR knockout) that remodeling gut BSH activity shifts the conjugated-bile-acid pool and engages intestinal FXR/FGF15 to downregulate hepatic Cyp7a1 — strengthens the gut→liver arm of the axis mechanistically, with cardiovascular endpoints not assessed. [animal-model] (novelty: 3)
- 2026-08-18 — Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.: 2026 multi-omics observational study in older adults: bile-acid metabolites surfaced within the microbiome–metabolome network linked to intrinsic capacity decline after multivariable adjustment, adding a human cross-sectional data point tying bile-acid pool composition to a functional-aging endpoint beyond cardiovascular/muscle-specific outcomes. [human-observational] (novelty: 3)
- 2026-06-08 — ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.: 2026 mouse study places hepatic ACAT3 upstream of the bile-acid axis: hepatocyte cholesterol esterification via ACAT3 modulates bile-acid pool composition and microbiota, and its expression falls with aging/obesity/diabetes — nominates a hepatic genetic lesion feeding age-related bile-acid remodeling, male mice only. [animal-model] (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: 2026 cardiac-aging crosstalk review invokes the gut–heart arm (including bile-acid/microbial-metabolite signaling) as one of four organ axes converging on cardiac senescence, providing broader context for the FXR/TGR5-based bile-acid mechanism — narrative synthesis, no new bile-acid measurements. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.
18-aug-2026
novelty 3
per-area 3
strengthens
Bile acids as a "new hormone" in aging-related liver disease.
07-aug-2026
novelty 2
per-area 2
strengthens
Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.
01-aug-2026
novelty 3
per-area 3
strengthens
β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.
21-jul-2026
novelty 3
per-area 3
strengthens
ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.
10-jul-2026
novelty 3
per-area 2
mentions
Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.
06-jul-2026
novelty 2
per-area 3
introduces
Liver- and Immune-Enriched Molecular Signatures Associated With Mortality in Older Adults.
01-jul-2026
novelty 3
per-area 2
mentions
ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.
08-jun-2026
novelty 3
per-area 3
strengthens